Partner Conference

Partner Conference

Supported by

Gondwanaland
Leipzig Skyline
Kongresshalle
Gondwanaland
Leipzig
Gondwanaland
Coffeebaum LeipzigLeipzig City
Gondwanaland

Guidelines

Poster presenter information

Posters must be designed in vertical format (DIN A0, height: 118 cm; width: 84 cm).
The poster boards will be marked with numbers referring to those down below. Materials for poster mounting will be provided.

 

Poster session I on Wednesday
April 20, 2016
Poster session II on Thursday
April 21, 2016
Mounting time:
Tuesday, April 19 after your registration
Mounting time:
Thursday, April 21 at latest until 10:00 am
Dismounting time:
Wednesday, April 20 at latest until 6:30 pm
Dismounting time:
Thursday, April 21 at latest until 06:00 pm

Poster that haven’t been removed until then will be removed by the staff. Please note that we cannot accept responsibility for lost material.

 

Time of presentation

The poster viewings take place between 1:00 and 2:30 pm. Please be present at your poster for possible questions to be asked.

 

Wednesday

The neurovasculature in stroke and dementia

P I – 1-1   
Beneficial effects of electroacupuncture on memory impairments and oligodendrocyte regeneration in a mouse model of prolonged cerebral hypoperfusion
Ahn S. M., Kim Y. R., Baek J. U., Shin H. K., Choi B. T.

P I – 1-2   
Decline of perineuronal nets and damaged GABAergic neurons in the nucleus reticularisthalami of wildtype and 3xTg mice after experimental cerebral ischemia
Härtig W., Appel S., Suttkus A., Grosche J., Michalski D.

P I – 1-3  
Anti-depressant effects of aripiprazole may involve a common CREB signaling pathway with cilostazol in chronic mild stress-treated mice after ischemic stroke
Kim Y. R., Kim H. N., Shin H. K., Choi B. T.

P I – 1-4  
Focus on vasculoprotection by the poly(ADP-ribose)polymerase inhibitor PJ34 after stroke and thrombolysis in mice
El Amki M., Lerouet D., Garraud M., Teng F., Beray-Berthat V., Coqueran B., Barsacq B., Abbou C., Palmier B., Marchand-Leroux C., Margaill I.

P I – 1-5   
Antenatal inflammation attenuates blood-brain barrier permeability after stroke in young adult mice
Mencl S., Neuhaus W., Förster C., Kleinschnitz C.

P I – 1-6   Rivaroxaban and apixaban reduce hemorrhagic complication by protection of neurovascular unit after thrombolysis in ischemic stroke of rat
Morihara R., Kono S., Yamashita T., Abe K.

P I – 1-7   
A novel 5-node feed forward loop to generate robust miRNA-TF regulatory network for cerebral ischemia
Nampoothiri S., Fayaz S. M., Rajanikant G. K.

P I – 1-8   
Angiotensin signaling blockade in the prevention of vascular dementia
Niedowicz D., Beckett T., Macheda T., Helman A., Kohler K., Powell D., Murphy M. P.

P I – 1-9   
Vasculo- and neuro-protective effect of Wharton jelly derived MSC and EPC on post-ischemic organotypic hippocampal slices
Obtulowicz P., Lech W., Strojek L., Sarnowska A., Domanska-Janik K.

Neuroprotection: molecular targets and further research directions


P I – 2-1   
The role of microglia in reducing oligodendrocyte precursor viability after chemotherapy and the protective effects of anti-depressant and anti-inflammatory treatments
Al-Bayti A. A., Rabiaa E., Lasio V., Fowler M., Wigmore P.

P I – 2-2   
Vitamin D3 improves decline in cognitive function and cholinergic transmission in prefrontal cortex of streptozotocin-induced diabetic rats
Alrefaie Z., Alhyani A.

P I – 2-3   
Angiotensin-(1-7) increases tissue salvage following cerebral ischaemia
Arroja M. M. C., Reid E., Holmes W., Nicklin S. A., Work L. M., McCabe C.

P I – 2-4   
Development of a neuroprotective peptide that interferes calpain-processing of NMDAR-GluN2A subunits reducing ischemic brain damage
Ayuso-Dolado S., Esteban-Ortega G. M., González-Camacho S., Tejeda G. S., Díaz-Guerra M.

P I – 2-5   
Protective effect of bone marrow mesenchymal stem cells transplantation against ischemic brain injury via JNK pathway regulation
Azami A., Vahidinia Z., Atlasi M., Nejati M., Beyer C.

P I – 2-6   
Aging induced alterations in Ezrin driven peripheral nerve regeneration
Büttner R., Schulz A., Baader S., Bauer R., Morrison H.

P I – 2-7   
Radicals and radical target repair as new therapeutic approaches in stroke
Casas A. I., Langhauser F., Mencl S., Göb E., Dao V. T., Guney E., Kleikers P., Lopez M. G.,
Menche J., László Barabási A., Kleinschnitz C., Schmidt H.

P I – 2-8   
Effects of SUMO modulation in neuroprotection and cellular function

Cerdeira M., Lättig G., Harms C.

P I – 2-9   
Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial polarization after focal ischemia in the neonatal mouse brain
Charriaut-Marlangue C., Moretti R., Leger P.- L., Pansiot J., Bonnin P., Baud O.

P I – 2-10   
Cyclophilin A/CD147 interactions participate in early brain injury after subarachnoid hemorrhage in rats
Dang B., Wang Z., Li H., Shen H., Chen G.

P I – 2-11   
Role of neurexin-1β and neuroligin-1 in cognitive dysfunction after subarachnoid hemorrhage in rats

Shen H., Gao A., Wang Z., Li H., Chen G.

P I – 2-12   
ydrogen sulfide ameliorates early brain injury following subarachnoid hemorrhage in rats
Cui Y., Yu Z., Li H., Shen H., Chen G.

P I – 2-13   
Conformations of tissue-type plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.
Chevilley A., Lenoir S., Lesept F., Bertrand T., Parcq J., Vivien D.

P I – 2-14   
Neuroprotection of atorvastatin against oxygen-glucose deprivation-induced neural stem cell death
Choi N.- Y.

P I – 2-15   
Effect of monomethyl-fumarate on experimental stroke
Clausen B. H., Lundberg L., Yli-Karjanmaa M., Martin N. A., Svensson M., Alfsen M. Z., Nielsen H. H., Finsen B., Deierborg T., Illés Z. L., Lambertsen K. L.

P I – 2-16   
Modulation of serotonin signaling has no effect on established amyloid pathology in the APPswePS1ΔE9 mouse model of Alzheimer’s disease
Severino M., Sivasaravanaparan M., Ørum Olesen L., von Linstow C. U., Metaxas A., Bouzinova E., Lambertsen K. L., Babcock A. A., Hasselstrøm J., Gramsbergen J. B., Wiborg O., Finsen B.

P I – 2-18   
Human iPSC derived neurons recorded by MEA technology: A powerful tool for functional assessment of in vitro neurotoxicity
Hess D., Luerman G., Guenther E., Bohlen H.

P I – 2-19   
Intravenously administered Interleukin-6 improves functional outcome after focal
cerebral ischemia without affecting infarct volu
mes

Hjortdal Groenhoej M., Hjelm Clausen B., Fenger C., Lykke Lambertsen K., Finsen B.

P I – 2-20   
Neuronal death after brain ischemia is blocked by interfering with the E2F4-regulated Orc1 de-novo transcription in neurons
Hübner D.

P I – 2-21   
Effects of clopidogrel resinate and clopidogrel bisulfate against oxygen glucose deprivation-induced neural stem cell death
Hwang M. A.

P I – 2-22   
The PTEN-long isoform influences AKT homeostasis and neuronal survival after ischemic stress
Jochner M. C. E., An J., Eickholt B. J., Harms C.

P I – 2-23   
Neuroprotection using intra-arterial cerebral endothelial cell transplantation in rat cerebral ischemia
Kim H.- S., Park M.- S., Choi K.- H.

P I – 2-24   
Proteomic analysis of the effect of acupuncture on suppressing kainic acid-induced neuronal destruction in mouse hippocampus
Kim S., Bae C.- H., Ryu S., Kim D.

P I – 2-25   
Effects of Sirt5 deletion and PKCε activation on the brain primary metabolome
Koronowski K., Stradecki H., Morris-Blanco K., Garrett T., Perez-Pinzon M.

P I – 2-26   
Long-term treatment of Statins has negative effects on neural stem cells through
inhibiting proliferation and inducing apoptosis
Lee E.- H.

P I – 2-27   
Transcranial low-level light therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke
Lee H. I., Lee S.- W., Kim N. G., Park K.- J., Choi B. T., Shin Y.- I., Shin H. K.

P I – 2-28   
Glyoxalase 1 determines the extent of neuronal injury
Pieroh P., Wagner D. C., Alessandri B., Dabbagh-Nazari M., Boltze J., Ehrlich A., Ghadban C., Hobusch C., Birkenmeier G., Dehghani F.

Future research directions in basic and clinical neuroscience


P I – 3-1   
Thermal plantar test in experimental ischemic stroke
Monza L., Cai R., Cuccione E., Pirovano S., Versace A., Riva M., Carone D., Ferrarese C., Beretta S.

P I – 3-2   
Acute high-fat diet in the absence of obesity worsens stroke outcome
Haley M., Krishnan S., Thakrar J., de Hoog L., Schiessl I., Allan S., Lawrence C.

P I – 3-3   
The stemness properties and neural differentiation potential of Wharton’s jelly-derived MSC depending on method of cell isolation
Lech W., Drela K., Strojek L., Sarnowska A., Domanska-Janik K.

P I – 3-4   
Brain plasticity under different social environment: molecular and behavioral changes
Lopatina O., Komleva Y., Gorina Y., Volkova V., Salmina A.

P I – 3-5   
Investigating neuroprotective small molecule inhibition of pro-apoptotic Bax and Bak with unbiased large scale 3d microscopy image analysis
Mergenthaler P., Hariharan S., Brahmbhatt H., Andrews D. W.

P I – 3-6   
Diagnostic value of neurotrophic factors detection during hypoxia
Mishchenko T., Vedunova M., Mitroshina E., Shchelchkova N., Terentieva K., Kosareva M.,
Khaletskaya O., Mukhina I.

P I – 3-7   
mRNA-driven overexpression of CD49d rodent mesenchymal stem cells for improved homing
Nitzsche F., Blümel S., Boltze J., Deten A.

P I – 3-8   
Autologous blood derived stem cell (ABDSCS) effects in the central nervous system: neurodegenerative pathologies improvements in non-provoked veterinary clinical cases
Polettini M.

P I – 3-9   
Modulation of extracellular matrix proteases in the rat somatosensory cortex is driven by experience-dependent plasticity during stroke recovery
Quattromani M. J., Pruvost M., Guerreiro C., Ruscher K., Vivien D., Wieloch T.

P I – 3-10   
The immunoproteasome in focal cerebral ischemia
Säring P., Landgraf P., Seifert U., Dieterich D. C.

P I – 3-11   
Perturbed cerebellar cortical development caused by postnatal increase of oxygen Scheuer T., Endesfelder S., Bührer C., Schmitz T.

P I – 3-12   
Combining Robotic Rehabilitation with silencing of the healthy hemisphere promotes True Motor Recovery in a Mouse model of Ischemic Injury
Spalletti C., Alia C., Lai S., Panarese A., Vallone F., Di Garbo A., Micera S., Caleo M.

P I – 3-13   
Electrophysiology in ipsc disease modeling: microelectrode array (MEA) and automated patch-clamp approaches
Stölzle-Feix S., Dragicevic E., Becker N., Millard D., Isaac C., Nicolini A., Fiene S., Chvatal S., George M., Fertig N.

P I – 3-14   
Longterm effects of thyroid hormones on recovery mechanisms after experimental stroke
Talhada D., Gonçalves I., Wieloch T., Santos C., Ruscher K.

P I – 3-15   
Novel cell transplantation therapy for stroke using induced neural stem cells
Yamashita T., Matsuzono K., Morihara R., Abe K.

P I – 3-16 
A new approach for selective cerebral hypothermia
Cattaneo G.

P I – 3-17   
In-vivo experience with a novel endovascular cooling catheter system for selective cerebral hypothermia
Meckel S., Schumacher M., Maurer C., Boos L., Shah M., Foerster K., Niesen W.-D., Ihorst G., Urbach H., Cattaneo G.

Neural and neuronal network pathology in neurotrauma and –degeneration / Understanding and controlling neuroinflammation


P I – 4-1 
  
Electrophysiological characterization of human induced pluripotent stem cell-derived dopaminergic neurons using manual and automated Patch Clamp systems
Franz D., Gimsa J., Klink O., Olsen H.

P I – 4-2   
Paracrine effects of human dental pulp stem cells on neuronal differentiation, neuritogenesis and migration of SH-SY5Y neuroblastoma cells
Gervois P., Wolfs E., Ratajczak J., Dillen Y., Vangansewinkel T., Hilkens P., Bronckaers A., Struys T., Lambrichts I.

P I – 4-3   
Effects of N-arachidonoyl glycine on neuronal injury
Grabiec U., Hohmann T., Antonietti A., Ghadban C., Rothgaenger C., Dehghani F.

P I – 4-4   
The effect of ALS IgGs on reactive oxygen species production and ph change in BV-2 cells
Milosevic M., Bijelic D., Dubaic M., Milicevic K., Giniatullin R., Andjus P.

P I – 4-5   
High level expression of neurotrophins in serum of patients with SMA type II - mechanism of the plasticity of the nervous system or of a factor which promotes further progression of the disease
Sokolova M., Penniyaynen V., Lobzin S.

P I – 4-6   
Prefrontal cortex stroke disrupts cholinergic pathways and impairs learning
Zhou L., Barwick D., Boltz C., Gowing E., Clarkson A.

P I – 4-7   
Dose dependent response to extracellular ATP: Activation of astrocytes and antioxidant defense system in vitro
Adzic M., Stevanovic I., Josipovic N., Milosevic M., Nedeljkovic N.

P I – 4-8   
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates microglial responses and affects subacute injury and repair after experimental stroke
Alfieri A., Davies C. L., McCulloch L., McColl B.

P I – 4-9   
Expression of Iba1+ and ED1+ cells in rat cortex, striatum and thalamus after cortical stroke: Time course study until 4 months
Anttila J., Airavaara M.

P I – 4-10   
Functional phenotypic comparison of activity patterns from different mouse brain region-specific neuron cultures with developing human iPSC-derived neuronal networks
Bader B. M., Ehnert C., Jügelt K., Schröder O. H.

P I – 4-11   
Intermediate molecules showing association between human ischemic brain and the peripheral blood
Azami-Tameh A., Bahmani B., Atlasi M., Beyer C., Aghadavoud E., Vousooghi N.

P I – 4-12   
Microvesicles: a novel mechanism for neuron-glia communication in ischemia
Couch Y., Gardiner C., Sargent I., Anthony D. C., Lambertsen K. L., Buchan A. M.

P I – 4-13   
Flow cytometric quantification of adhesion molecule expression on choroid plexus epithelial cells in healthy and diseased mice
Didwischus N., Pösel C., Weise G., Wagner D.- C.

P I – 4-14  
Novel classification of infiltrating dendritic cell subpopulations in a murine model of ischemic stroke
Gallizioli M., Gelderblom M., Orthey E., Planas A. M., Magnus T.

P I – 4-15   
Probucol attenuates inflammation in LPS-stimulated microglia and cerebral ischemia in normal and hyperlipidemic mice
Jung Y. S., Kim H., Park J. H., Kim S. Y., Lee S.- W., Choi B. T., Shin H. K.

P I – 4-16  
Neuroprotective role of a novel lipophilic PPARδ agonist in ischemic brain injury in miceKnauss S., Hindinger C., Blaschke F., Endres M., Kunz A.

P I – 4-17   
Inflammasomme and inflammatory mediators expression in astrocytes astrocytes in the neurodegeneration
Komleva Y., Gorina Y., Lopatina O., Malinovskaya N., Panina Y., Chernykh A., Volkova V., Salmina A.

P I – 4-18   
Exploring myeloid cell function following cerebral ischaemia in the absence of spontaneous infection

Krishnan S., Grainger J., Smith C., Allan S., Lawrence C.

P I – 4-19   
The choroid plexus in post-stroke cerebral leukocyte invasion
Llovera G., Hellal F., Arzberger T., Engelhardt B., Liesz A.

P I – 4-20   
Diversity and mechanisms of CNS myeloid cell accumulation in experimental stroke
Davies C. L., Alfieri A., McCulloch L., McColl B.

P I – 4-21   
DS2 has an anti-inflammatory effect and improves stroke recovery
Neumann S., Gowing E., Lateef Z., Chebib M., Young S., Clarkson A. N.

P I – 4-22   
Beware the intruder: Analysis of neutrophil-microglia interactions after stroke in real time
Riek-Burchardt M., Henneberg S., Müller A., Gunzer M., Neumann J.

P I – 4-23   
Alcohol consumption alter the central and systemic inflammatory responses after stroke
Drieu A., Lemarchand E., Quenault A., Vivien D., Rubio M.

P I – 4-24   
An inverse relationship between the severity of brain injury and the magnitude of the acute phase response in the early post-natal period
Sá-Pereira I., Stolp H. B., Roodeslaar J., Anthony D. C.

P I – 4-25   
Hyperglycemia-mediated decrease of CSFf-1 expression in the brain endothelium leads to a reduction in tissue protective M2 macrophages after ischemic stroke
Schultz S., Khan M. A., Schwaninger M.

P I – 4-26   
Investigating mediators of neutrophil recruitment to the brain with near-infrared fluorescence imaging
Vaas M., Enzmann G., Licha K., Rudin M., Engelhardt B., Klohs J.

Glial cells, the blood brain barrier and the neurovascular unit


P I – 5-1
   
From gene expression to functionality - the adhesive and migratory properties of genetically modified human mesenchymal stem cells
Andrzejewska A., Nowakowski A., Janowski M., Koniusz S., Walczak P., Grygorowicz T., Jablonska A., Lukomska B.

P I – 5-2   
Ischemic postconditioning promotes recovery in the neurovascular unit by stimulating neurogenesis and angiogenesis via BDNF and MMP9 released by astrocytes
Esposito E., Hayakawa K., Arai K., Lo E. H.

P I – 5-3   
Mitochondrial membrane potential changes in astrocytes under oxygen and glucose deprivation and the alternative energy metabolism
Korenic A., Boltze J., Andjus P., Radenovic L.

P I – 5-4   
Ischemia-induced endothelial degeneration is consistently associated to BBB breakdown in various models of focal cerebral ischemia
Krueger M., Bechmann I., Reichenbach A., Härtig W., Michalski D.

P I – 5-5   
Astrocytes protect neural stem cells from effect of chemotherapy
Rabiaa E., Al-Bayati A., Lasio V., Al-Harganee A., Fowler M., Smith P., Wigmore P.

P I – 5-6   
IBA-1 clustering characterizes microglial pathology in Alzheimer’s disease
Tischer J., Krüger M., Müller W., Staszewski O., Prinz M., Streit W. J., Bechmann I.

P I – 5-7   
TAK1 and NEMO protect the blood-brain barrier and prevent brain endothelial cell death
Wenzel J., Ridder D. A., Müller K., Tong X.- K., Korpos E., Schmidt-Supprian M., Pasparakis M., Sorokin L. M., Hamel E., Schwaninger M.

 

Thursday

Traumatic brain injury and hemorrhagic stroke


P II – 1-1   
Neuroprotective effects of resveratrol and docosahexaenoic acid antioxidants in
perinatal hypoxic-ischemic brain injury in rats

Arteaga O., Revuelta M., Uriguen L., Martinez-Ibarguen A., Martinez-Millan L., Hilario E., Alvarez A.

P II – 1-2  
The balance of Id3 and E47 determines neural stem/precursor cell differentiation into astrocytes
Bohrer C., Pfurr S., Mammadzada K., Schildge S., Plappert L., Hils M., Pous L., Rauch K., Dumit V., Pfeifer D., Dengjel J., Kirsch M., Schachtrup K., Schachtrup C.

P II – 1-3   
Deficiency of Factor XII minimizes brain damage after experimental traumatic brain injury
Hopp S., Albert-Weissenberger C., Mencl S., Sirén A.- L., Kleinschnitz C.

P II – 1-4  
Using zebrafish to model haemorrhagic stroke
Kasher P., Fotiou E., Webb K., Hudson G., Goosey L., Parry-Jones A., Crow Y., Allan S.

P II – 1-5   
Hemorrhagic stroke model in sheep: A magnet resonance imaging study of morphology, perfusion and diffusion using statistical parametric mapping
Nitzsche B., Dreyer A., Boltze J., Barthel H., Lobsien D., Gräßer F., Ferrera F.

P II – 1-6  
Incidence of hemorrhagic transformation after transient ischemic stroke in rats.
Rewell S., Humphrys L., Howells D.

P II – 1-7   
Astroglial cells produce a stem cell niche-like extracellular matrix after cortical laser lesions in the mouse
Roll L., Eysel U. T., Faissner A.

Neuroprotection: molecular targets and further research directions


P II – 2-1   
The steroid hormone progesterone induces expression of Down-regulated NMDA receptor subunits in ischemic rats
Aftabi Y., Azami-Tameh A., Karimian M., Beyer C., Ali Atlasi M.

P II – 2-2   
Post-insult treatment with a combination of epigenetic drugs is neuroprotective in a mouse model of permanent middle cerebral artery
Coelho da Mota M., Porrini V., Schultz S., Schwaninger M., Pizzi M.

P II – 2-3   
Zfp580 expression a
nd post- translational modification as a target of endogenous neuroprotection in mouse models of brain ischemia
Lorenz S., Hoffmann C. J., Jochner M., Dopatka M., Endres M., Harms C.

P II – 2-4   
Distribution and in vivo secretome of bone marrow stromal cells in the cerebrospinal fluid compartment, after experimental stroke
Lourbopoulos A., Mueller S., Mamrak U., Hellal F., Lichtenthaler S., Plesnila N.

P II – 2-5   
The mode of CDNF delivery determines whether it is neuroprotective against ischemic brain injury
Mätlik K., Anttila J., Lindholm P., Harvey B., Arumäe U., Airavaara M.

P II – 2-6   
The role of microglia in the development of AD: Is it really a matter of loss of function?

Mazzitelli S.

P II – 2-7    Role of cytoskeletal elements during stroke evolution and potential implications for future treatment
Michalski D., Krueger M., Härtig W.

P II – 2-8   
Sex differences in response to MEK1/2 inhibition after ischemic stroke
Mostajeran M., Arkelius K., Ahnstedt H., Edvinsson L., Ansar S.

P II – 2-9   
Neuroprotective effects of carbamylated erythropoietin (CEPO) via the erythropoietin/CD131 heteroreceptor complex in mice
Mukhina I., Schelchkova N., Loginov P., Samsonova K., Kluev E., Muravieva M., Shirokova O., Kukharenko A.

P II – 2-10   
Nimodipine enhances post-ischaemic cerebral blood flow and improves behavioural outcomes in rat transient middle cerebral artery occlusion
Neuhaus A., Couch Y., Sutherland B., Buchan A.

P II – 2-11   
Long-acting calcium channel bloker DHP protects neural stem cells against oxygen-glucose deprivation/reoxygenation by Restoring the function of damaged mitochondria
Park H.

P II – 2-12   
Electroacupuncture preconditioning reduces reactive oxygen species generation and blood-brain barrier dysfunction after ischemic stroke
Jung Y. S., Lee S.- W., Park J. H., Yun Y. J., Choi B. T., Shin H. K.

P II – 2-13   
The neuroprotective properties of ethyl pyruvate in excitotoxicity are microglia independent
Pieroh P., Wagner D. C., Grabiec U., Boltze J., Ehrlich A., Ghadban C., Hobusch C., Birkenmeier G., Dehghani F.

P II – 2-14   
The study of the neurotropic peptides role in cell responses regulation

Pinelis V., Gretskaya N., Shramm S., Surin A., Besuglov V., Andreeva L., Myasoedov N.

P II – 2-15   
Acid sensing ion channels (ASIC) in brain endothelial cells as pH sensors in epilepsy. Do they play a neuroprotective role?
Radu B. M., Banciu A., Radu M., Merigo F., Banciu D. D., Tsenov G., di Chio M., Bertini G., Fabene P. F.

P II – 2-16   
The role of acute phase protein pentraxin 3 in inflammation and angiogenesis after
ischaemic stroke

Rajkovic I.

P II – 2-17   
Reactive oxygen species (ROS)-responsive nanotechnology: therapeutic action of nanoparticles in stroke

Rajkovic O.

P II – 2-18
Central blockade of Mas receptor worsens outcome following transient MCAO in a rat model of genetic hypertension
Reid E., Arroja M., Holmes W., Nicklin S., Work L., McCabe C.

P II – 2-19   
Gene expression pattern after neonatal hypoxic-ischemic injury and modification after treatment administration in rat brainstem
Revuelta M., Arteaga O., Álvarez A. D. L., Martinez A., Hilario E.

P II – 2-20   
Beneficial effect of ethanol beyond the therapeutic window of rt-PA: pre-clinical study in a model of thromboembolic stroke
Rubio M., Lemarchand E., Lebehot A., Chevilley A., Vivien D., Ali C.

P II – 2-21   
Neuroprotective effect of ghrelin on long-term potentiation in the hippocampal dentate gyrus and memory impairment following streptozotocin-induced diabetes
Sadeghi B.

P II – 2-22   
Perlecan LG3 is neuroprotective when administered intra-arterially after experimental ischemic stroke
Salmeron K., Maniskas M., Fraser J., Bix G.

P II – 2-23   
New synthetic peptide protects neurons from death induced by toxic influences of glutamate and activated mast cells via protease-activated receptor 1 type

Savinkova I., Strukova S., Sidorova M., Gorbacheva L.

P II – 2-24   
Selective non-nuclear estrogen receptor activation decreases stroke severity and promotes functional recovery after stroke in mice
Selvaraj U. M., Plautz E., Chambliss K., Kong X., Rovinsky S., Zhang S., Mineo C., Tegene M., Ortega S., Katzenellenbogen B., Katzenellenbogen J., Hoon Kim S., Shaul P., Stowe A.

P II – 2-25   
GDNF influence on the functional neural networks reorganization in the ischemic factors modeling in vitro
Shishkina T., Vedunova M., Mishchenko T., Mitroshina E., Babaev A., Pimashkin A., Kazantsev V., Mukhina I.

P II – 2-26   
Gut microbiota alterations after ischemic stroke impact immunity and brain tissue injury

Singh V., Roth S., Stecher B., Liesz A.

P II – 2-27   
The novel vaccine peptide GV1001 effectively protects from brain against ischemia/reperfusion injury by mimicking the extra-telomeric functions of human telomerase reverse transcriptase.
Son J., Koh S.- H.

P II – 2-28   
Poly(ADP-ribose)polymerase-1 (PARP-1) impact on glutamate-induced disturbance of calcium concentration in cultured neurons
Surin A., Pinelis V., Gorbacheva L., Shram S., Krasilnikova I., Efremova A., Savinkova I., Persiantseva N.

P II – 2-29   
A specific nutritional intervention with Fortasyn as therapeutic approach after ischemic stroke
Wiesmann M., Zinnhardt B., Hellwich M., Eligehausen S., Reinhardt D., Dederen P. J. W., Broersen L. M., Heerschap A., Jacobs A. H., Kiliaan A. J.

P II – 2-30   
Dopamine agonists rescue amyloid β induced LTP impairment by Src-family tyrosine kinases
Xiang P. Y., Janc O., Grochowska K. M., Kreutz M. R., Reymann K. G.

Imaging and novel diagnostics / Post-stroke immunity: has the time come for clinical trials? / The neurovasculature in stroke and dementia / Clinical translation: from bench to bedside and back


P II – 3-1  
Quantifying neurite dynamics in human iPSC-derived neuronal mono- and co-cultures using long term live-cell imaging
Alcantara S., Brown J., Rauch J., Gedge L., Garay P., McGillicuddy L., O’Callaghan T., Dale T., McEwen D., Appledorn D., Trezise D. J., McManus O.

P II – 3-2   
Combined diffusion and sodium magnetic resonance imaging identifies potentially salvegable tissue after transient experimental stroke

Wetterling F., Chatzikonstantinou E., Tritschler L., Meairs S., Fatar M., Schad L., Ansar S.

P II – 3-3   
Sensitive imaging techniques demonstrate short-chain fatty acid-induced improvement of functional connectivity, metabolic and cerebrovascular function in obesogenic LDLr-/- Leiden mice
Arnoldussen I., Wiesmann M., Pelgrim C., Wielemaker E., van Duyvenvoorde W., Kleemann R., Heerschap A., Wielinga P., Kiliaan A.

P II – 3-4   
Automatic and quantitative analysis tool for crossover neural cell in high through-put screeningOng K. H., De J., Cheng L., Ahmed S., Yu W. M.

P II – 3-5   
Confirmation, Classification and Sub-classification of Strokes in UK Biobank

Osborne S., Ngoh K., Wilkinson T., Schnier C., Al-Shahi Salman R., Rannikmae K., Zhang Q., Sudlow C.

P II – 3-6   
Evaluation of multiple sclerosis patients through parameters of diffusion tensor
magnetic imaging and correlation with clinical features

Rostamzadeh A., Masoumi H., Salehi M. G., Farzizadeh M.

P II – 3-7   
Quantitative assessment of blood-brain barrier permeability and cell damage after cortical ischemia - role of free radicals
Schoknecht K., Prager O., Vazana U., Kamintsky L., Kovács R., Dreier J., Friedman A., Heinemann U.

P II – 3-8   
Does a multi-nutrient diet have similar beneficial effects on stroke in female mice as it has in male mice?
Timmer N., Wiesmann M., Zinnhardt B., Eligehausen S., Reinhardt D., Jacobs A., Kiliaan A.

P II – 3-9   
Imaging therapy effects of a multi-nutrient diet on microglial activation in experimental stroke.
Zinnhardt B., Wiesmann M., Eligehausen S., Broersen L., Wachsmuth L., Faust A., Fricke I. B., Schelhaas S., Hermann S., Faber C., Kuhlmann M. T., Schäfers M., Kiliaan A. J., Jacobs A. H.

P II – 3-10   
Imaging of STAiR18 - a long noncoding RNA highly expressed in Alzheimer`s disease

Zipfel I., Binder S., Horn F.

P II – 3-11   
Immunosuppressive properties of human Mesenchymal stem cells transplanted in brain ischemic rats: false or fact?
Koniusz S., Andrzejewska A., Nowakowski A., Janowski M., Lukomska B.

P II – 3-12   
Loss of splenic marginal zone B cells after ischemic stroke and relevance to post-stroke infection
McCulloch L., Smith C. J., McColl B.

P II – 3-13   
Therapeutic Potential Of Ribose, Adenine And Allopurinol In Transient Focal Cerebral Ischaemia - A Pilot Study
Faller K., Holmes W. M., Macrae I. M., Frenguelli B. G.

P II – 3-14   
Optimization of low oxygen human adipose-derived mesenchymal stem cell culture which favour cells propagation with parallel enhancement of their stem properties
Figiel-Dabrowska A., Lech W., Obtulowicz P., Zychowicz M., Domanska-Janik K., Sarnowska A.

P II – 3-15   
Points of Entry: Decoding the Current Clinical Paradigm in Acute Stroke Intervention for Scientific Innovation
Fraser J., Bix G.

P II – 3-16   
Transplantation of ephrin-B2 stimulated peripheral blood mononuclear cells from diabetic patients enhances post-stroke recovery in mice
Kubis N., Hilal R., Poittevin M., Pasteur-Rousseau A., Cogo A., Mangin G., Launay J.- M., Gautier J.- F., Lévy B., Merkulova T.

P II – 3-17   
Low level laser therapy vs. methylprednisolone administration for improvement of pain threshold and motor function in male rats with spinal cord injury
Mojarradlangroudi N., Janzadeh A., Nasirinezhad F.

Rehabilitation and human brain plasticity


P II – 4-1   
Biofeedback therapy improved hand function and activities of daily living performances in stroke survivors
Haghgoo H. A., Haji Ahmad T., Pishyareh E.

P II – 4-2   
Describing the process of family adaptation to activities of daily living in older adults with stroke

Haghgoo H. A.

P II – 4-3   
D
escribing the strategies used to adapt with disorders in activities of daily living performances in older adults with stroke
Haghgoo H. A.

P II – 4-4   
Structural factors involve in the process of family adaptation to disorders in activities
of daily living in stroke survivors

Haghgoo H. A.

P II – 4-8   
After-effects of anodal transcranial direct current stimulation on the excitability of the motor cortex in rats
Koo H., Shin Y.- I., Kim M. S., Kim Y.- H., Park M., Yoon J. A.

P II – 4-9   
Association between Genetic Variation in Dopamine System and Motor Recovery after StrokeLee J., Kim B.- R., Kim H., Lee H. Y., Choi D.- H., Kim H. Y., Yun Y. M.

P II – 4-11   
Repeated anodal transcranial direct current stimulation induces neural plasticity-
associated gene expression in the rat cortex and hippocampus

Shin Y.- I., Koo H., Kim M. S., Kim Y.- H., Park M., Ko S.

P II – 4-12   
Physical exercise after cardiac arrest reduces cognitive deficits and synaptic dysfunction
Stradecki H., Cohan C., Youbi M., Dave K., Perez-Pinzon M.

P II – 4-13   
Rehabilitation of patients with lesion of the facial nerve by means of acupuncture and moxibustion
Tsoy R.

P II – 4-14   
Moderate physical exercise promotes cognitive recovery following focal cerebral
ischemia in rats

Youbi M., Cohan C., Stradecki H., Tiozzo E., Dave K., Wright C., Sacco R., Perez-Pinzon M.

Current controversies and novel hypotheses in neuroprotection and neurorepair / The neurovasculature in stroke and dementia


P II – 5-1   
Curcumin improves sensorimotor impairment and the excitability of spinal cord induced by lead during development
Benammi H., ElHiba O., Vinay L., Bras H., Viemari J.- C., Gamrani H.

P II – 5-2  
Influence of different Noldus CatWalk analysis modes on outcome reporting in one mouse stroke study.
Bernard R., Mosch L., Rex A., Dirnagl U.

P II – 5-3   
Role of Remak cells in peripheral nerve regeneration

Carlstedt A., Büttner R., Schulz A., Morrison H.

P II – 5-4   
Gliptins (Dipeptidyl peptidase-4 inhibitor)-mediated neuroprotection against stroke requires chronic pre-treatment and is Glucagon-like peptide-1 receptor-independent
Darsalia V., Larsson M., Lietzau G., Nathanson D., Nyström T., Klein T., Patrone C.

P II – 5-5  
Association of GSTP1 Ile105Val polymorphism with risk of Alzheimer’s disease: evidences from five case-control studies   
Karimian M., Bahmani B., Naderian H., Beyer C., Azami-Tameh A.

P II – 5-6   
Recovery of forepaw function after stroke: Does the cortex matter?
Knab F., Grittner U., Böhm-Sturm P., Koch S., Bernard R., Müller S., Foddis M., Lips J., Euskirchen P., Zerbe N., Hufnagel P., Rex A., Dirnagl U., Farr T. D., Harms C.

P II – 5-7   
Migration and survival of glial restricted precursors grown as single cells or neurospheres embedded in hyaluronic acid-based hydrogels with the prospect of using them as intrathecally injectable composites.
Malysz-Cymborska I., Kalkowski L., Golubczyk D., Janowski M., Wojtkiewicz J., Walczak P.

P II – 5-8   
Preliminary results of the application of mesenchymal stem cells for the post-
vaccination encephalopathy in 3 years old child

Milczarek O., Jarocha D., Starowicz - Filip A., Kwiakowski S., Majka M.

P II – 5-9   
Can an alternative surgical approach reduce variability and improve outcome within a preclinical stroke model?
Trotman M., Kelly M., Janus J., Gibson C.

P II – 5-10   
The effects of anti-TNF treatment on cell proliferation

Yli-Karjanmaa M., Hjelm Clausen B., Gram Novrup H., Karabiyik C., Carlsen S., Szymkowski D., Stubbe J., Frich L. H., Meyer M., Lambertsen K. L.